Cell and Gene Outsourcing

  1. Viral Safety Timeline 2/27/2026

    Evolving science, contamination cases, and regulatory shifts shaped modern viral‑safety standards, prompting adoption of inactivation, filtration, molecular detection, and risk‑based methods.

  2. AgentSCREEN™ GMP Adventitious Virus Detection By NGS 2/27/2026

    A GMP‑qualified NGS method improves viral safety through broad, sensitive detection, quicker results, regulatory alignment, and rich data for lifecycle evaluation.

  3. Case Study: From Variability To Validation – GMP Bioassay Success Through Partnership 2/27/2026

    When a biopharma company needed GMP validation for an established bioassay, they faced hurdles. They turned to Solvias. 

  4. Revolutionizing Gene Therapy Manufacturing: Robotics, ML For Process Intensification 2/25/2026

    By integrating perfusion into upstream manufacturing, see how this approach has achieved up to a fivefold increase in productivity, delivering titers that significantly exceed current industry benchmarks.

  5. Using Rapid Development Framework™ To Accelerate CGT Development, Manufacturing 2/25/2026

    Learn how the following framework can accelerate your viral vector, CAR-T, and iPSC programs, reduce risk, and streamline your path from development to commercial manufacturing.

  6. NGS AAT For Cell Line Characterization 2/24/2026

    A modern sequencing‑based assay strengthens cell line characterization with greater sensitivity. See how it supports confident, objective safety decisions and helps reduce risk during early development.

  7. What Defines Excellence In CMC Analytics? 2/21/2026

    In this podcast, our Chief Scientific Officer, Daniel Galbraith, shares candid insights into what separates operational vendors from true scientific collaborators. 

  8. How To Fast-Track Your Oral Solid Dose To Phase 1 2/17/2026

    A strategic approach accelerates oral solid dose development by uniting molecular analysis, solubility improvement, formulation design, manufacturing efficiency, and stability testing to reach Phase 1 faster.

  9. Practical USP <1665>/<665> Guide To E&L Risk Assessment 2/17/2026

    A practical USP <1665> and <665> framework helps manufacturers evaluate and manage extractables and leachables risk, supporting quality, safety, and regulatory compliance.

  10. USP <382> Functional Suitability & CCI Testing 2/17/2026

    USP <382> testing assesses packaging integrity, safety, and performance using deterministic CCIT and functional evaluations to support validation and regulatory submissions.